source
- Moderna cancer vaccine data lifts investor confidence, shares jump to multi-year highsModerna has long said it wants to broaden its portfolio beyond infectious-disease vaccines. The company has been working on a cancer vaccine and investors have been waiting for late-stage trial res…
- Vaccine makers say splitting MMR vaccine is impractical despite presidential directiveVaccine manufacturers responded to a recent order from President Donald Trump to separate the combined measles, mumps and rubella (MMR) vaccine, noting that while the concept is theoretically possi…